Pacific Biosciences Q3 Adj EPS $(0.27) Beats $(0.32) Estimate, Sales $55.69M Beat $48.76M Estimate

Pacific Biosciences of California, Inc. -0.39%

Pacific Biosciences of California, Inc.

PACB

5.11

-0.39%

Pacific Biosciences (NASDAQ: PACB) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.32) by 15.62 percent. This is a 15.62 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $55.69 million which beat the analyst consensus estimate of $48.76 million by 14.21 percent. This is a 72.36 percent increase over sales of $32.31 million the same period last year.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via